Chromatin-linked adaptor for MSL proteins: Biological Overview | References
Gene name - Chromatin-linked adaptor for MSL proteins
Cytological map position - 40F2-40F2
Function - zinc finger transcription factor
Keywords - dosage compensation - essential in both males and females - also functions outside of the dosage compensation pathway.
Symbol - Clamp
FlyBase ID: FBgn0032979
Genetic map position - chr2L:22,165,720-22,169,143
NCBI classification - Zinc finger, C2H2 type
Cellular location - nuclear
|Recent literature||Urban, J., Kuzu, G., Bowman, S., Scruggs, B., Henriques, T., Kingston, R., Adelman, K., Tolstorukov, M. and Larschan, E. (2017). Enhanced chromatin accessibility of the dosage compensated Drosophila male X-chromosome requires the CLAMP zinc finger protein. PLoS One 12(10): e0186855. PubMed ID: 29077765
The essential process of dosage compensation is required to equalize gene expression of X-chromosome genes between males (XY) and females (XX). In Drosophila, the conserved Male-specific lethal (MSL) histone acetyltransferase complex mediates dosage compensation by increasing transcript levels from genes on the single male X-chromosome approximately two-fold. Consistent with its increased levels of transcription, the male X-chromosome has enhanced chromatin accessibility, distinguishing it from the autosomes. This study demonstrates that the non-sex-specific CLAMP (Chromatin-linked adaptor for MSL proteins) zinc finger protein that recognizes GA-rich sequences genome-wide promotes the specialized chromatin environment on the male X-chromosome and can act over long genomic distances (~14 kb). Although MSL complex is required for increasing transcript levels of X-linked genes, it is not required for enhancing global male X-chromosome chromatin accessibility, and instead works cooperatively with CLAMP to facilitate an accessible chromatin configuration at its sites of highest occupancy. Furthermore, CLAMP regulates chromatin structure at strong MSL complex binding sites through promoting recruitment of the Nucleosome Remodeling Factor (NURF) complex. In contrast to the X-chromosome, CLAMP regulates chromatin and gene expression on autosomes through a distinct mechanism that does not involve NURF recruitment. Overall, these results support a model where synergy between a non-sex-specific transcription factor (CLAMP) and a sex-specific cofactor (MSL) creates a specialized chromatin domain on the male X-chromosome.
|Urban, J. A., Urban, J. M., Kuzu, G. and Larschan, E. N. (2017). The Drosophila CLAMP protein associates with diverse proteins on chromatin. PLoS One 12(12): e0189772. PubMed ID: 29281702
Gaining new insights into gene regulation involves an in-depth understanding of protein-protein interactions on chromatin. A powerful model for studying mechanisms of gene regulation is dosage compensation, a process that targets the X-chromosome to equalize gene expression between XY males and XX females. Previous work has identified a zinc finger protein in Drosophila melanogaster that plays a sex-specific role in targeting the Male-specific lethal (MSL) dosage compensation complex to the male X-chromosome, called the Chromatin-Linked Adapter for MSL Proteins (CLAMP). CLAMP has been found to have non-sex-specific roles as an essential protein that regulates chromatin accessibility at promoters genome-wide. To identify associations between CLAMP and other factors in both male and female cells, two complementary mass spectrometry approaches were used. This study demonstrates that CLAMP associates with the transcriptional regulator complex Negative Elongation Factor (NELF; see Nelf-E) in both sexes and determine that CLAMP reduces NELF recruitment to several target genes. In sum, this study has identified many new CLAMP-associated factors and provide a resource for further study of this little understood essential protein.
Heterogametic species require chromosome-wide gene regulation to compensate for differences in sex chromosome gene dosage. In Drosophila melanogaster, transcriptional output from the single male X-chromosome is equalized to that of XX females by recruitment of the male-specific lethal (MSL) complex, which increases transcript levels of active genes 2-fold. The MSL complex contains several protein components and two non-coding RNA on the X (roX) RNAs that are transcriptionally activated by the MSL complex. Targeting of the MSL complex to the X-chromosome has been shown to be dependent on the Chromatin-linked adapter for MSL proteins (CLAMP) zinc finger protein. To better understand CLAMP function, the CRISPR/Cas9 genome editing system was used to generate a frameshift mutation in the clamp gene that eliminates expression of the CLAMP protein. clamp null females were found to die at the third instar larval stage, while almost all clamp null males die at earlier developmental stages. Moreover, it was found that in clamp null females roX gene expression is activated, whereas in clamp null males roX gene expression is reduced. Therefore, CLAMP regulates roX abundance in a sex-specific manner. These results provide new insights into sex-specific gene regulation by an essential transcription factor (Urban, 2017).
Many species employ a sex determination system that generates an inherent imbalance in sex chromosome copy number, such as the XX/XY system in most mammals and some insects. In this system, one sex has twice the number of X-chromosome-encoded genes compared to the other. Therefore, a mechanism of dosage compensation is required to equalize levels of X-linked transcripts, both between the sexes and between the X-chromosome and autosomes. Dosage compensation is an essential mechanism that corrects for this imbalance by coordinately regulating the gene expression of most X-linked genes (Urban, 2017).
In Drosophila melanogaster, transcription from the single male X-chromosome is increased 2-fold by recruitment of the male-specific lethal (MSL) complex. The MSL complex is composed of two structural proteins, MSL1 and MSL2, three accessory proteins, MSL3, males absent on the first (MOF), and maleless (MLE), and two functionally redundant non-coding RNAs, RNA on the X (roX1) and roX2. Previous work has shown that recruitment of the MSL complex to the X-chromosome requires the zinc finger protein chromatin-linked adapter for MSL proteins (CLAMP) (Soruco, 2013; Urban, 2017 and references therein).
In addition to its role in male MSL complex recruitment, it was suggested that CLAMP has an additional non-sex-specific essential function because targeting of the clamp transcript by RNA interference results in a pupal lethal phenotype in both males and females (Soruco, 2013). Further understanding of CLAMP function in the context of the whole organism required a null mutant. However, due to the pericentric location of the clamp gene, no deficiencies or null mutations were available. Using the CRISPR/Cas9 system, a frameshift mutation was introduced in the clamp gene, leading to an early termination codon before the major zinc finger binding domain. This frameshift mutation generated the clamp2 allele, which eliminates detectable CLAMP protein production and is therefore a protein null allele. The majority of clamp2 mutant males die prior to the third instar stage. On the other hand, females die at the third instar stage, suggesting sex-specific functions for CLAMP. Furthermore, CLAMP regulates the roX genes in a sex-specific manner, activating their accumulation in males and repressing their accumulation in females. Overall, we present a new tool for studying dosage compensation and suggest that CLAMP functions to assure that roX RNA accumulation is sex specific (Urban, 2017).
Previous work demonstrated that CLAMP has an essential role in MSL complex recruitment to the male X-chromosome (Soruco, 2013). However, it was not possible to perform in vivo studies to further investigate CLAMP function because there was no available null mutant line. The current work present a CLAMP protein null mutant and determine that this protein is essential in both sexes. This allele will provide a key tool for future in vivo studies on the role of CLAMP in dosage compensation, as well as identification of the essential function of CLAMP in both sexes (Urban, 2017).
The initial characterization of the clamp2 protein null allele revealed sexually dimorphic roles for CLAMP in regulation of the roX genes. CLAMP was seen to promotes roX2 transcription in males but represses transcription of both roX genes in females. It is likely that recruitment of the MSL complex to the roX2 locus by CLAMP promotes roX2 expression in males. In females, where the MSL complex is not present, CLAMP may function to repress these loci as an additional mechanism to ensure that dosage compensation is male-specific. Additionally, it was determined that most clamp2 homozygous males die earlier in development than clamp2 homozygous females. Earlier lethality in males is likely due to a misregulation of the dosage compensation process as a result of the loss of CLAMP-mediated MSL complex recruitment. However, CLAMP is enriched at the 5' regulatory regions of thousands of genes across the genome. Therefore, it is likely that other non-sex-specific regulatory pathways are disrupted resulting in female lethality (Urban, 2017).
Furthermore, CLAMP is an essential protein because our CRISPR/Cas9-generated protein null clamp allele is homozygous lethal in both males and females. These results indicate that CLAMP has a previously unstudied non-sex-specific role that is essential to the viability of both males and females. An interesting observation that arose from this characterization is that polytene chromosome organization is disrupted in clamp2 mutant females, suggesting that CLAMP may play a role in regulation of genome-wide chromatin organization of interphase chromosomes. A function in regulating chromatin organization provides one possible explanation for how CLAMP performs sexually dimorphic functions. For example, CLAMP may repress roX expression in females by promoting the recruitment of a repressive chromatin-modifying factor in the absence of the MSL complex. In contrast, CLAMP may activate roX2 in males by creating a chromatin environment permissive for MSL complex recruitment in males. Although roX1 and roX2 are functionally redundant, the results suggest that CLAMP specifically activates roX2 but not roX1 in males. Interestingly, Villa (2016) recently reported that roX2, but not roX1, is likely to be an early site of MSL complex recruitment (Villa, 2016), suggesting that CLAMP may function early in the process of dosage compensation (Urban, 2017).
Overall, the newly generated clamp2 protein null allele provides an important tool to study how the essential CLAMP protein regulates its many target genes in vivo. The generation of the clamp2 allele will facilitate future studies that will reveal a mechanistic understanding of how a single transcription factor can promote different sex-specific functions within an organism (Urban, 2017).
Dosage compensation is an essential process that equalizes transcript levels of X-linked genes between sexes by forming a domain of coordinated gene expression. Throughout the evolution of Diptera, many different X-chromosomes acquired the ability to be dosage compensated. Once each newly evolved X-chromosome is targeted for dosage compensation in XY males, its active genes are upregulated two-fold to equalize gene expression with XX females. In Drosophila melanogaster, the CLAMP zinc finger protein links the dosage compensation complex to the X-chromosome. However, the mechanism for X-chromosome identification has remained unknown. This study combined biochemical, genomic and evolutionary approaches to reveal that expansion of GA-dinucleotide repeats likely accumulated on the X-chromosome over evolutionary time to increase the density of CLAMP binding sites, thereby driving the evolution of dosage compensation. Overall, this study presents new insight into how subtle changes in genomic architecture, such as expansions of a simple sequence repeat, promote the evolution of coordinated gene expression (Kuzu, 2016).
Upon the evolution of heterogametic species, the process of dosage compensation became essential to ensure the appropriate balance of gene expression between males and females and the X and autosomes. Distinguishing the X-chromosome from autosomes is the key step in this process because MSL complex must be targeted to the correct chromosome to ensure the fidelity of dosage compensation. This study has demonstrate that in several species this process likely involved enriching the evolving X-chromosomes for long GA-repeat binding sites that can be recognized by the highly conserved CLAMP protein that recruits MSL complex (Kuzu, 2016).
CLAMP binding sites are not X-specific as the CLAMP protein binds to similar GA-rich sequences all over the genome. It is proposed that a higher density of sites within CES that contain longer GA-repeats evolved to optimize CLAMP binding on X to better target MSL complex for dosage compensation. Then, it is likely that the increased density of CLAMP at CES functions together with other cofactors with known roles in MSL complex recruitment such as H3K36me3 and roX RNAs. Once this initial process of X-chromosome identification occurs, synergistic interactions between maternally loaded CLAMP and the MSL complex  increase the X-enrichment of both factors (Kuzu, 2016).
Interestingly, the CLAMP motif is much longer than most transcription factor binding sites. It is possible that the length of the CLAMP binding site ensures specificity by reducing the promiscuity of its binding and allowing it to compete with other similar proteins. In addition, recent work on transcriptional regulators in budding yeast has implicated the sequence context of transcription factor binding sites outside of the core binding site as critical for the recognition process. Therefore, current approaches to identifying transcription factor binding site motifs have likely underestimated their length due to the approaches used that often allow detection of only short motifs. In the future, it will be important to determine transcription factor recognition motifs using approaches like gcPBM that uses in vivo sequences to identify direct binding site motifs (Kuzu, 2016).
There are several mechanisms by which the GA-repeat number could have been increased including expansions due to slippage of DNA polymerase. Helitron transposons containing GA-rich sequences have also been implicated in the X-enrichment of these sequences in D. miranda. It is possible that expansions of GA dinucleotides occurred within these transposons after they landed on the X-chromosome. These GA-repeat expansions could have been further propagated by gene conversion events that also occurred during the evolution of dosage compensation. Finally, long repeat sequences such as the 1.688 elements that produce siRNAs function during dosage compensation via an unknown mechanism (Menon, 2014). Therefore, it is possible that GA-repeat elements have been expanded over evolutionary time because of a general role in promoting dosage compensation. To support this hypothesis, a recent report identified GA-rich binding motifs almost identical to those that we characterized as CLAMP binding sites within the strongest MSL complex binding sites in three additional Drosophila species (Kuzu, 2016).
Motifs that contain GA-repeats have been implicated in diverse processes that all involve generating open chromatin regions. GA-repeat containing motifs are highly enriched at sites that promote pausing of RNA Polymerase II and at developmentally regulated DNase I hypersensitivity sites. Furthermore, a GA-repeat motif is one of the two motifs that are enriched at genes that are activated first during the maternal to zygotic transition. The well-studied GAGA factor (GAF) protein also recognizes similar sequences to the CLAMP protein and has been implicated in pausing of RNA Polymerase II and opening of chromatin. Overall, it is likely that the dosage compensation machinery has evolved to take advantage of targeting GA-repeats that mark open chromatin regions to ensure that it only identifies active genes for further transcriptional upregulation by the MSL complex (Kuzu, 2016).
It is possible that GA-rich sequences have roles in dosage compensation outside of Diptera. For example, it has been proposed that upregulation of the single active X occurs in mammals and this process is mediated by targeting the conserved MOF histone acetyltransferase component of MSL complex. Moreover, GA-repeats were found to be significantly enriched within regions of the X-chromosome that escape X-inactivation (X escape regions). There are no strong homologues of CLAMP in mammals but there are several possible functional orthologs such as the ETS family transcription factor GABP1 (GA binding protein-1). Furthermore, in C. elegans, there is an early upregulation of both X-chromosomes that is also mediated by the MOF histone acetyltransferase. One of the zinc finger proteins that targets the C. elegans dosage compensation machinery is SCC-2 (sister chromatid cohesion-2) which recognizes a GA-repeat sequence very similar to the CLAMP binding motif. Therefore, it is possible that GA-repeats are involved in dosage compensation beyond Diptera and this will be an exciting area for future investigation (Kuzu, 2016).
The Drosophila male-specific lethal (MSL) dosage compensation complex increases transcript levels on the single male X chromosome to equal the transcript levels in XX females. However, it is not known how the MSL complex is linked to its DNA recognition elements, the critical first step in dosage compensation. This study demonstrated that a previously uncharacterized zinc finger protein, CLAMP (chromatin-linked adaptor for MSL proteins), functions as the first link between the MSL complex and the X chromosome. CLAMP directly binds to the MSL complex DNA recognition elements and is required for the recruitment of the MSL complex. The discovery of CLAMP identifies a key factor required for the chromosome-specific targeting of dosage compensation, providing new insights into how subnuclear domains of coordinate gene regulation are formed within metazoan genomes (Soruco, 2013).
To determine whether CLAMP and the MSL complex colocalize at 'chromatin entry sites' CESs in vivo, CLAMP chromatin immunoprecipitation (ChIP) sequencing (ChIP-seq) experiments were performede in male SL2 cells and CLAMP occupancy profiles were compared with available MSL complex occupancy profiles. CLAMP occupancy was found at many loci throughout the genome (X: 2695; autosomes: 10,009) and strong colocalization was found with MRE sequences. Moreover, CLAMP and the MSL complex exhibit their highest occupancy levels when colocalized. Nonoverlapping CLAMP occupancy sites occur at 5' ends of active genes on all chromosomes, and nonoverlapping MSL-binding sites are localized over the bodies of active X-linked genes. Furthermore, CLAMP sites occur precisely over MREs within CESs compared with the broader domains of MSL complex occupancy. Together, these patterns are consistent with a role for CLAMP in recruiting the MSL complex to CESs, followed by spreading of the MSL complex to the bodies of active genes and additional non-sex-specific roles for CLAMP at 5' ends of active genes (Soruco, 2013).
Next, the MEME software package was used to generate a position weight matrix (PWM) representing the most enriched sequence within 500 regions surrounding CLAMP occupancy sites (2 kb each) at the 5' and 3' ends of genes genome-wide. All CLAMP localization motifs on the X chromosome and on autosomes shared an 8-bp GA-rich core region that is very similar to the previously identified MRE consensus sequence. Therefore, it was hypothesized that CLAMP functions as an MRE recognition factor (Soruco, 2013).
To test this hypothesis, the in vitro DNA-binding specificity of CLAMP was characterized. Protein-binding microarrays (PBMs) was used to assay CLAMP binding to all possible 10-bp sequences. Each PBM is a dsDNA array that contains all possible 10-bp sequences embedded within variable flanking sequences. After testing the complete seven-finger CLAMP construct and many additional combinations of zinc fingers, it was possible able to express soluble protein for the C-terminal six-finger and four-finger zinc finger regions of CLAMP. The in vitro PBM analysis for these proteins yielded statistically significant 8-bp motifs with high PBM enrichment, in excellent agreement with the CLAMP in vivo binding-site motif and the previously defined MRE consensus. Therefore, CLAMP binds directly to the MRE motif in vitro (Soruco, 2013).
Next, whether MREs are required for the recruitment of CLAMP in vivo in male and female larvae was examined using available stocks with three intact or mutated MREs embedded within a minimal 150-bp fragment of CES5C2 inserted site specifically into an autosomal location. Occupancy of both the MSL complex and CLAMP is greater on the X chromosome compared with the autosomal insertion. The autosomal insertion with three intact MREs shows greater occupancy of CLAMP than that in which the 8-bp core of each of the three MREs is mutated. Therefore, MREs are required for CLAMP recruitment in both males and females, as expected for a non-sex-specific factor (Soruco, 2013).
To determine whether enrichment at CESs is specific to CLAMP or is a common feature shared with other factors that can recognize MRE-like sequences, a well-characterized Drosophila DNA-binding protein, the GAGA factor (GAF), was examined. In contrast to CLAMP, which is strongly enriched at CESs, GAF occupancy was lower at CESs compared with other GAF-binding sites throughout the genome. These data suggest that CLAMP, but not GAF, directly recognizes MRE elements within CESs. In addition, CLAMP was recently shown to physically associate with the MSL complex on chromatin using an approach that combined ChIP with mass spectrometry (Wang, 2013). Therefore, CLAMP directly recognizes MREs and physically associates with the MSL complex, providing the first link between the MSL complex and the X chromosome (Soruco, 2013).
Previous studies demonstrated that CLAMP is required for recruitment of the MSL complex to five CESs in SL2 male tissue culture cells (Larschan, 2012). To determine whether CLAMP is required for MSL complex recruitment to the entire X chromosome in flies, a publicly available RNAi transgenic Drosophila line was used to reduce CLAMP mRNA levels. Because CLAMP is highly expressed in all tissues, the RNAi construct was expressed ubiquitously. Although the CLAMP RNAi construct did not completely eliminate CLAMP mRNA levels, immunostaining of polytene chromosomes for CLAMP and CLAMP ChIP occupancy were strongly reduced. CLAMP RNAi causes a pupal lethal phenotype in both males and females (Larschan, 2012; Soruco, 2013 and references therein).
Next, ChIP for the MSL2 core component was examined to examine MSL complex recruitment to five CESs in the presence and absence of CLAMP RNAi treatment. The results showed that CLAMP RNAi strongly reduced the occupancy of the MSL complex in male larvae. H3 occupancy was measured by ChIP to determine whether CLAMP RNAi globally disrupts chromatin and only modest changes were found after CLAMP RNAi. Also, polytene staining for the MSL3 protein was performed after CLAMP RNAi and no detectable MSL3 staining was observed, revealing that CLAMP is required for MSL complex recruitment to the entire X chromosome. Thus, CLAMP promotes MSL complex localization to the entire X chromosome in flies (Soruco, 2013).
It was previously shown that loss of targeting of the MSL complex reduces complex stability, likely due to ubiquitylation of complex members by MSL2. Therefore, measuring MSL protein levels after CLAMP RNAi would not distinguish between effects on complex stability and targeting to the X chromosome. However, it has been demonstrated previously that CLAMP RNAi does not affect mRNA levels of MSL complex components (Larschan, 2012), and CLAMP is strongly enriched at 92% of CESs, suggesting that indirect effects on MSL complex stability are unlikely (Larschan, 2012; Soruco, 2013 and references therein).
The MSL complex is highly enriched on the X chromosome compared with autosomal controls but mediates at most a twofold increase in transcription. Furthermore, only a 1.4-fold decrease in expression of X-linked genes is seen after MSL2 RNAi in male SL2 cells. To determine how CLAMP regulates gene expression globally, mRNA sequencing (mRNA-seq) experiments were conducted in male SL2 cells before and after CLAMP RNAi treatment. As expected for a non-sex-specific factor present on both the X chromosome and autosome, CLAMP RNAi caused changes in gene expression genome-wide. However, CLAMP RNAi caused a greater decrease in the gene expression of X-linked genes compared with autosomal genes, consistent with a function in MSL complex targeting. Consistent with its localization throughout the genome and enrichment on the X chromosome, CLAMP RNAi affects gene expression on both the X chromosome and autosomes with a bias toward X-linked genes (Soruco, 2013).
In contrast to average X-linked genes, the genes that encode the roX noncoding RNA components are highly dependent on the MSL complex. Therefore, this study measured the levels of roX RNAs before and after CLAMP RNAi treatment by quantitative RT-PCR (qRT-PCR) in male and female third instar larvae. In males, roX2 Levels were reduced fourfold after CLAMP RNAi, indicating that CLAMP serves as an activator of roX2 expression. In contrast, roX1 levels were largely unchanged in males after CLAMP RNAi. In females, roX1 was significantly increased after CLAMP RNAi treatment (6.5-fold), and roX2 levels remained largely unchanged. These patterns of CLAMP-mediated regulation agree with the established differential regulation of roX1 and roX2 and recent genetic evidence implicating roX2 as the first site of X identification (Soruco, 2013).
CLAMP is enriched on the X chromosome independent of the MSL complex Identifying CLAMP as the protein that directly recognizes MREs provides a key opportunity to reveal new insight into the process of X identification. It was hypothesized that X enrichment of CLAMP independent of the MSL complex would indicate that CLAMP could function as a beacon on the X chromosome to distinguish it from autosomes (Soruco, 2013).
To determine how the MSL complex regulates CLAMP occupancy, a comparison was made of CLAMP occupancy at MREs on the X chromosome and on autosomes in male cells before and after MSL2 RNAi and in female cells that lack the MSL complex. Overall, the percentage of MREs occupied by CLAMP was greater on the X chromosome when compared with autosomes in both male cells (50% on X vs. 32% on autosomes) and female cells (62% on X vs. 38% on autosomes). Therefore, CLAMP is enriched at X-chromosome MREs compared with autosomal MREs, independent of the MSL complex (Soruco, 2013).
Next, how CLAMP occupancy varies in its dependence on the MSL complex at MREs within CESs was determined. To define the total number of likely CESs for subsequent analysis, how the largest class of previously characterized CESs (306 loci) overlapped with CLAMP sites present in male cells was determined and 265 common sites (87% overlap) were found. Next, these sites were clustered based on their overall binding pattern and occupancy level of CLAMP in male cells, male cells after hypomorphic MSL2 RNAi, and female cells. The average occupancy at each of these classes of CESs was plotted compared with the average CLAMP site on the X chromosome and the autosome. In this way, three distinct classes of CESs were defined. Group A: Largely MSL-dependent CESs exhibit a strongly decreased CLAMP occupancy in the absence of the MSL complex, and their occupancy in female cells is much below that of the average CLAMP site (177 sites). Group B: Partially MSL-dependent CESs, including both roX loci, exhibit higher than average levels of CLAMP occupancy in the absence of the MSL complex and further increase in their occupancy and breadth in the presence of the MSL complex (43 sites). Group C: Largely MSL-independent CESs have higher than average CLAMP occupancy in both male and female cell lines (45 sites). ChIP-qPCR was used to validate these classes in both cell culture and larvae (Soruco, 2013).
Thus, group B and group C CESs, including both roX loci, have higher than average levels of MSL-independent CLAMP occupancy compared with group A sites, which have lower than average MSL-independent CLAMP occupancy. These data suggest that group B and group C CESs may function as beacons to promote X identification because they are occupied by CLAMP independent of the MSL complex. In addition, CLAMP associates with chromatin interdependently at group A and group B sites. Therefore, synergistic interactions between CLAMP and the MSL complex at group A and group B sites likely increase the occupancy of both factors (Soruco, 2013).
To define additional common features that distinguish each subclass of CESs, the following properties were compared: the number of tandem MREs within each CES, the two-dimensional clustering of CESs along the X chromosome, and the average nucleosome occupancy in the absence of the MSL complex. First, a strong increase was found in the percentage of group B and group C sites with three or more tandem MREs present within each CES locus compared with group A sites. Second, group B sites are clustered in two dimensions along the length of the X within a 5-Mb region surrounding roX2, with the majority of sites between the roX genes. In contrast, group A sites are uniformly distributed, and group C sites exhibit minimal clustering distal to the group B sites. Third, chromatin organization was examined at each subclass of sites in the absence of the MSL complex using publicly available female cell data sets. Under high-salt extraction conditions, which are likely to provide the most accurate nucleosome occupancy profiles over CESs, the decreased nucleosome density at group B and group C loci in female cells resembles that previously reported for male cells (Soruco, 2013).
In summary, the number of tandem MREs within each CES locus, two-dimensional clustering along the length of the X chromosome, and MSL-independent nucleosome occupancy are features that distinguish subclasses of CESs and were not previously identified by analysis of the average properties of all CESs. By defining three distinct subclasses of CESs, this study has provide a new tool for examining how the MSL complex identifies the X chromosome (Soruco, 2013).
The identification of CLAMP as the previously unknown link that tethers the MSL complex to the X chromosome supports the following mechanism for X identification: (1) Prior to MSL complex targeting, maternally loaded CLAMP binds directly to MREs within group B and group C CESs, including roX loci, due to clustering of tandem MREs within these loci. (2) During early embryogenesis, MSL-independent transcription of roX genes is stimulated and is likely to facilitate cotranscriptional MSL complex assembly. CLAMP is enriched at the CESs adjacent to roX loci independent of the MSL complex and tethers the MSL complex to the X chromosome. (3) The MSL complex catalyzes acetylation of H4K16 (H4K16ac), thereby opening chromatin and increasing the accessibility of MRE sequences for recognition by CLAMP. Synergistic interactions between the MSL complex and CLAMP are likely to contribute to the high occupancy of both factors at the roX loci, followed by spreading to additional CESs. Through this proposed mechanism, we suggest that CLAMP functions together with roX RNAs to target the MSL complex to the X chromosome. The high degree of conservation of both CLAMP and MREs across Drosophila species (Alekseyenko, 2013) suggests that they are key components of a conserved mechanism for establishing an active chromatin domain within a metazoan genome (Soruco, 2013).
Search PubMed for articles about Drosophila Clamp
Alekseyenko, A. A., Ellison, C. E., Gorchakov, A. A., Zhou, Q., Kaiser, V. B., Toda, N., Walton, Z., Peng, S., Park, P. J., Bachtrog, D. and Kuroda, M. I. (2013). Conservation and de novo acquisition of dosage compensation on newly evolved sex chromosomes in Drosophila. Genes Dev 27(8): 853-858. PubMed ID: 23630075
Kuzu, G., Kaye, E. G., Chery, J., Siggers, T., Yang, L., Dobson, J. R., Boor, S., Bliss, J., Liu, W., Jogl, G., Rohs, R., Singh, N. D., Bulyk, M. L., Tolstorukov, M. Y. and Larschan, E. (2016). Expansion of GA dinucleotide repeats increases the density of CLAMP binding sites on the X-chromosome to promote Drosophila dosage compensation. PLoS Genet 12(7): e1006120. PubMed ID: 27414415
Larschan, E., Soruco, M. M., Lee, O. K., Peng, S., Bishop, E., Chery, J., Goebel, K., Feng, J., Park, P. J. and Kuroda, M. I. (2012). Identification of chromatin-associated regulators of MSL complex targeting in Drosophila dosage compensation. PLoS Genet 8(7): e1002830. PubMed ID: 22844249
[, D. U., Coarfa, C., Xiao, W., Gunaratne, P. H. and Meller, V. H. (2014). siRNAs from an X-linked satellite repeat promote X-chromosome recognition in Drosophila melanogaster. Proc Natl Acad Sci U S A 111(46): 16460-16465. PubMed ID: 25368194
Soruco, M. M., Chery, J., Bishop, E. P., Siggers, T., Tolstorukov, M. Y., Leydon, A. R., Sugden, A. U., Goebel, K., Feng, J., Xia, P., Vedenko, A., Bulyk, M. L., Park, P. J. and Larschan, E. (2013). The CLAMP protein links the MSL complex to the X chromosome during Drosophila dosage compensation. Genes Dev 27(14): 1551-1556. PubMed ID: 23873939
Urban, J. A., Doherty, C. A., Jordan, W. T., Bliss, J. E., Feng, J., Soruco, M. M., Rieder, L. E., Tsiarli, M. A. and Larschan, E. N. (2016). The essential Drosophila CLAMP protein differentially regulates non-coding roX RNAs in male and females. Chromosome Res [Epub ahead of print]. PubMed ID: 27995349
Villa, R., Schauer, T., Smialowski, P., Straub, T. and Becker, P. B. (2016). PionX sites mark the X chromosome for dosage compensation. Nature 537(7619): 244-248. PubMed ID: 27580037
Wang, C. I., Alekseyenko, A. A., LeRoy, G., Elia, A. E., Gorchakov, A. A., Britton, L. M., Elledge, S. J., Kharchenko, P. V., Garcia, B. A. and Kuroda, M. I. (2013). Chromatin proteins captured by ChIP-mass spectrometry are linked to dosage compensation in Drosophila. Nat Struct Mol Biol 20(2): 202-209. PubMed ID: 23295261
date revised: 3 August 2017
Home page: The Interactive Fly © 2011 Thomas Brody, Ph.D.